Company: EDSA
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001171843-25-000864
Chunk: 1

Company: Edesa Biotech, Inc.
Filing Date: 2025-02-14
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
         99.1      Press release issued by Edesa Biotech, Inc. dated February 14, 2025.         
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  EDESA BIOTECH, INC.                               
  By:                      /s/ Stephen Lemieux      
                           Stephen Lemieux          
                           Chief Financial Officer